IS4628A - Frumuröð sem myndar kvalastillandi efni til nota í meðferð gegn sársauka - Google Patents
Frumuröð sem myndar kvalastillandi efni til nota í meðferð gegn sársaukaInfo
- Publication number
- IS4628A IS4628A IS4628A IS4628A IS4628A IS 4628 A IS4628 A IS 4628A IS 4628 A IS4628 A IS 4628A IS 4628 A IS4628 A IS 4628A IS 4628 A IS4628 A IS 4628A
- Authority
- IS
- Iceland
- Prior art keywords
- pain
- treatment
- cell series
- produces
- relieving substances
- Prior art date
Links
- 239000000126 substance Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/70—Enkephalins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48191795A | 1995-06-07 | 1995-06-07 | |
| PCT/US1996/009629 WO1996040959A1 (en) | 1995-06-07 | 1996-06-07 | Cell line producing analgesic compounds for treating pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS4628A true IS4628A (is) | 1997-12-04 |
Family
ID=23913905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS4628A IS4628A (is) | 1995-06-07 | 1997-12-04 | Frumuröð sem myndar kvalastillandi efni til nota í meðferð gegn sársauka |
Country Status (20)
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999028449A2 (en) * | 1997-11-28 | 1999-06-10 | Medical Research Council | Yac vectors |
| WO2000016799A1 (en) * | 1998-09-23 | 2000-03-30 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Methods of treating chronic pain |
| US6372489B1 (en) | 1998-10-27 | 2002-04-16 | Anticancer, Inc. | Method and model for hair pigmentation |
| ATE312916T1 (de) * | 1998-10-27 | 2005-12-15 | Anticancer Inc | Herstellung eines retrovirus, welches den mel- lokus von streptomyces enthält, sowie dessen expression in säugetierzellen |
| US6903244B1 (en) | 1999-02-26 | 2005-06-07 | University Of Utah Research Foundation | Mice which are +/− or −/− for the elastin gene as models for vascular disease |
| AU2002952993A0 (en) | 2002-11-29 | 2002-12-12 | The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland | Therapeutic and diagnostic agents |
| NZ547767A (en) | 2003-12-24 | 2010-05-28 | Inst Medical W & E Hall | Therapeutic agents and uses therefor |
| EP1766389A4 (en) | 2004-05-12 | 2008-08-27 | Inst Medical W & E Hall | METHOD OF ISOLATING CELLS |
| DK2407484T3 (en) | 2005-06-24 | 2016-09-05 | The Walter And Eliza Hall Inst Of Medical Res | Therapeutic pro-apoptotic BH3-like molecules, and methods of generating and / or selecting those |
| CA2657532C (en) | 2006-07-18 | 2019-06-18 | University Of Utah Research Foundation | Methods for treating pain and screening analgesic compounds |
| US8889173B2 (en) * | 2008-04-18 | 2014-11-18 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for treatment of pain and/or inflammation |
| EP3003344B1 (en) | 2013-05-31 | 2020-11-25 | University of Utah Research Foundation | Conotoxin peptides, pharmaceutical compositions and uses thereof |
| JP6877419B2 (ja) | 2015-10-27 | 2021-05-26 | ザ ユニバーシティー オブ クイーンズランド | 治療の方法およびそのために有用な剤 |
| CN107964047B (zh) * | 2017-12-18 | 2018-11-02 | 哈尔滨工业大学 | 基于内吗啡肽-1和神经降压素(8-13)的嵌合肽及其合成方法和应用 |
| CN112891337A (zh) * | 2021-03-26 | 2021-06-04 | 河北医科大学 | 高良姜素及其衍生物在制备预防和治疗神经系统疾病药物中的用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1179350A3 (en) * | 1993-08-12 | 2003-01-02 | Cytotherapeutics, Inc. | Encapsulated cell system for implantation into the human CNS |
-
1996
- 1996-06-05 IN IN1039CA1996 patent/IN181898B/en unknown
- 1996-06-06 AR ARP960102993A patent/AR004494A1/es unknown
- 1996-06-07 IL IL12241596A patent/IL122415A0/xx unknown
- 1996-06-07 HU HU9901191A patent/HUP9901191A2/hu unknown
- 1996-06-07 SK SK1679-97A patent/SK167997A3/sk unknown
- 1996-06-07 WO PCT/US1996/009629 patent/WO1996040959A1/en not_active Application Discontinuation
- 1996-06-07 TR TR97/01520T patent/TR199701520T1/xx unknown
- 1996-06-07 KR KR1019970708894A patent/KR19990022414A/ko not_active Withdrawn
- 1996-06-07 AU AU62636/96A patent/AU6263696A/en not_active Abandoned
- 1996-06-07 ZA ZA964880A patent/ZA964880B/xx unknown
- 1996-06-07 PL PL96323867A patent/PL323867A1/xx unknown
- 1996-06-07 EE EE9700326A patent/EE9700326A/xx unknown
- 1996-06-07 CA CA002223246A patent/CA2223246A1/en not_active Abandoned
- 1996-06-07 EP EP96921403A patent/EP0833935A1/en not_active Withdrawn
- 1996-06-07 CN CN96195750A patent/CN1192246A/zh active Pending
- 1996-06-07 BR BR9608746A patent/BR9608746A/pt unknown
- 1996-06-07 CZ CZ973924A patent/CZ392497A3/cs unknown
- 1996-06-07 JP JP9501908A patent/JPH11507530A/ja active Pending
-
1997
- 1997-12-02 NO NO975545A patent/NO975545L/no unknown
- 1997-12-04 IS IS4628A patent/IS4628A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL122415A0 (en) | 1998-06-15 |
| BR9608746A (pt) | 1999-05-11 |
| TR199701520T1 (xx) | 1998-04-21 |
| CA2223246A1 (en) | 1996-12-19 |
| AU6263696A (en) | 1996-12-30 |
| SK167997A3 (en) | 1998-05-06 |
| NO975545L (no) | 1998-02-04 |
| EE9700326A (et) | 1998-06-15 |
| ZA964880B (en) | 1997-01-07 |
| PL323867A1 (en) | 1998-04-27 |
| CZ392497A3 (cs) | 1998-12-16 |
| NO975545D0 (no) | 1997-12-02 |
| WO1996040959A1 (en) | 1996-12-19 |
| KR19990022414A (ko) | 1999-03-25 |
| AR004494A1 (es) | 1998-12-16 |
| IN181898B (enrdf_load_stackoverflow) | 1998-10-24 |
| HUP9901191A2 (hu) | 1999-08-30 |
| CN1192246A (zh) | 1998-09-02 |
| EP0833935A1 (en) | 1998-04-08 |
| JPH11507530A (ja) | 1999-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2006007I1 (el) | Χρηση αναστολεων cgmp-φωσφοδιεστερασης στην αγωγη της ανικανοτητας | |
| ID17156A (id) | Zat-zat anti koagulan yang berguna dalam pengobatan trombosis | |
| EE03512B1 (et) | Epinastiin kasutamiseks valude ravis | |
| DE69630947D1 (de) | Mittel zur schmerzbehandlung | |
| DE69825447D1 (de) | Gerät zur dermatologischen behandlung | |
| IS4628A (is) | Frumuröð sem myndar kvalastillandi efni til nota í meðferð gegn sársauka | |
| EP0925046A4 (en) | TOPICAL PREPARATIONS AND METHODS FOR TREATING HEMORRHOIDS | |
| FR2759581B1 (fr) | Dispositif de traitement, notamment par moxa, de type acupressure | |
| PT966447E (pt) | Moleculas pequenas uteis no tratamento de doencas inflamatorias | |
| ATE381353T1 (de) | Verbesserungen in oder an kontrastmitteln | |
| FI972205A0 (fi) | cGmp-PDE:n estäjiä erektiohäiriön hoidossa | |
| DK1047428T3 (da) | Anvendelse af morpholinol til behandlingen af seksualforstyrrelser | |
| IL114229A0 (en) | Compositions for applying active substances to or through the skin | |
| DE59500555D1 (de) | Mittel zur Wasserbehandlung | |
| IS5405A (is) | Prostaglandín gerandefni og notkun þeirra til að meðhöndla beintruflanir | |
| ATA46794A (de) | Einrichtung zur behandlung von hautzonen | |
| AU7696098A (en) | Substance p inhibitors in combination with nmda-blockers for treating pain | |
| IS5504A (is) | Samsetning virk við meðhöndlun á getuleysi | |
| DE69931799D1 (de) | Absorptionsbeschleuniger und diese enthaltende zubereitungen zur transdermalen absorption | |
| DE69527749D1 (de) | Kugelförmige Aktivkohle zur Behandlung von Bauchentzündungen | |
| IS4274A (is) | Imidasópýridínsambönd til að nota við meðhöndlun sjúkdóma í meltingarvegi | |
| PT946175E (pt) | Utilizacao de uma combinacao de inibidores de h+, k+ -atpase e de glucocorticiodes no tratamento de polipos nasais | |
| DK0898566T3 (da) | Substituerede benzylaminer og anvendelse deraf til behandling af depression | |
| FI963099L (fi) | Vedenkäsittelymenetelmä ja -laite | |
| DE60003550D1 (de) | Substituierte 3-pyridyl-4-arylpyrrole und deren einsatz in verfahren zur therapeutischen und prophylaktischen behandlung |